Cargando…

Structure–Activity Relationships and Transcriptomic Analysis of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors

To evaluate the differences in action of commercially available 2-oxoglutarate mimetics and “branched-tail” oxyquinoline inhibitors of hypoxia-inducible factor prolyl hydroxylase (HIF PHD), the inhibitors’ IC(50) values in the activation of HIF1 ODD-luciferase reporter were selected for comparative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poloznikov, Andrey A., Nikulin, Sergey V., Hushpulian, Dmitry M., Khristichenko, Anna Yu., Osipyants, Andrey I., Asachenko, Andrey F., Shurupova, Olga V., Savin, Svyatoslav S., Lee, Sue H., Gaisina, Irina N., Thatcher, Gregory R. J., Narciso, Anthony, Chang, Eric P., Kazakov, Sergey V., Krucher, Nancy, Tishkov, Vladimir I., Thomas, Bobby, Gazaryan, Irina G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868400/ https://www.ncbi.nlm.nih.gov/pubmed/35204103 http://dx.doi.org/10.3390/antiox11020220

Ejemplares similares

HIF Prolyl Hydroxylase Inhibitors for COVID-19 Treatment: Pros and Cons
por: Poloznikov, Andrey A., et al.
Publicado: (2021)

Neuroprotective Effect of HIF Prolyl Hydroxylase Inhibition in an In Vitro Hypoxia Model
por: Savyuk, Maria, et al.
Publicado: (2020)

Probable Mechanisms of Doxorubicin Antitumor Activity Enhancement by Ginsenoside Rh2
por: Popov, Alexander, et al.
Publicado: (2022)

Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson’s Disease
por: Smirnova, Natalya A., et al.
Publicado: (2016)

9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells
por: Poloznikov, Andrey, et al.
Publicado: (2021)

Bach1 derepression is neuroprotective in a mouse model of Parkinson’s disease
por: Ahuja, Manuj, et al.
Publicado: (2021)

Highly efficient synthesis of 3,4-diarylbutadiene sulfones using Heck–Matsuda reaction
por: Shurupova, Olga V., et al.
Publicado: (2022)

Challenges and Limitations of Targeting the Keap1-Nrf2 Pathway for Neurotherapeutics: Bach1 De-Repression to the Rescue
por: Hushpulian, Dmitry M., et al.
Publicado: (2021)

One-Pot Modified Madelung Synthesis of 3-Tosyl- and 3-Cyano-1,2-disubstituted Indoles
por: Sterligov, Grigorii K., et al.
Publicado: (2022)

Towards embedding Caco-2 model of gut interface in a microfluidic device to enable multi-organ models for systems biology
por: Sakharov, Dmitry, et al.
Publicado: (2019)

ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis
por: Nikulin, Sergey, et al.
Publicado: (2023)

Degradation Kinetics of Disulfide Cross-Linked Microgels: Real-Time Monitoring by Confocal Microscopy
por: Mercer, Iris G., et al.
Publicado: (2023)

Impedance Spectroscopy as a Tool for Monitoring Performance in 3D Models of Epithelial Tissues
por: Gerasimenko, Tatiana, et al.
Publicado: (2020)

The role of HIF prolyl hydroxylases in tumour growth
por: Jokilehto, Terhi, et al.
Publicado: (2010)

Function and expression of prolyl hydroxylase 3 in cancers
por: Liu, Qiu-long, et al.
Publicado: (2013)

Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular risk
por: Harlow, Charli E, et al.
Publicado: (2022)

Tryptophan Hydroxylase-2-Mediated Serotonin Biosynthesis Suppresses Cell Reprogramming into Pluripotent State
por: Sinenko, Sergey A., et al.
Publicado: (2023)

HIF-independent role of prolyl hydroxylases in the cellular response to amino acids
por: Durán, R V, et al.
Publicado: (2013)

Structure and Mechanism of a Viral Collagen Prolyl Hydroxylase
por: Longbotham, James E., et al.
Publicado: (2015)

Structural Basis of Prolyl Hydroxylase Domain Inhibition by Molidustat
por: Figg, William D., et al.
Publicado: (2021)

Role of prolyl hydroxylase domain proteins in bone metabolism
por: Wolf, David, et al.
Publicado: (2022)

LAMA4-Regulating miR-4274 and Its Host Gene SORCS2 Play a Role in IGFBP6-Dependent Effects on Phenotype of Basal-Like Breast Cancer
por: Shkurnikov, Maxim, et al.
Publicado: (2019)

Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
por: Chowdhury, Rasheduzzaman, et al.
Publicado: (2016)

Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
por: Yeh, Tzu-Lan, et al.
Publicado: (2017)

Prolyl 4 Hydroxylase: A Critical Target in the Pathophysiology of Diseases
por: Kant, Ravi, et al.
Publicado: (2013)

The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma
por: Hatzimichael, E, et al.
Publicado: (2012)

Prolyl-hydroxylase 3: evolving roles for an ancient signaling protein
por: Place, Trenton L, et al.
Publicado: (2013)

Role of prolyl hydroxylase domain proteins in the regulation of insulin secretion
por: Huang, Mei, et al.
Publicado: (2016)

Prolyl hydroxylase domain enzymes: important regulators of cancer metabolism
por: Yang, Ming, et al.
Publicado: (2014)

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
por: Yum, Soohwan, et al.
Publicado: (2017)

An Arabidopsis Prolyl 4 Hydroxylase Is Involved in the Low Oxygen Response
por: Konkina, Anna, et al.
Publicado: (2021)

Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis
por: Pignata, Paola, et al.
Publicado: (2021)

Microbiota-derived butyrate is an endogenous HIF prolyl hydroxylase inhibitor
por: Wang, Ruth X., et al.
Publicado: (2021)

Inhibition of HIF-prolyl hydroxylases improves healing of intestinal anastomoses
por: Strowitzki, Moritz J., et al.
Publicado: (2021)

Role of prolyl hydroxylase/HIF-1 signaling in vascular calcification
por: Negri, Armando Luis
Publicado: (2022)

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
por: Ogawa, Chie, et al.
Publicado: (2023)

Hypoxia inducible factor prolyl hydroxylases in inflammatory bowel disease
por: Lun, Jie, et al.
Publicado: (2023)

Ribonucleoside Hydrolases–Structure, Functions, Physiological Role and Practical Uses
por: Shaposhnikov, Leonid A., et al.
Publicado: (2023)

Complement C1q is hydroxylated by collagen prolyl 4 hydroxylase and is sensitive to off-target inhibition by prolyl hydroxylase domain inhibitors that stabilize hypoxia-inducible factor
por: Kiriakidis, Serafim, et al.
Publicado: (2017)

Use of cyclic peptides to induce crystallization: case study with prolyl hydroxylase domain 2
por: Chowdhury, Rasheduzzaman, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7s6a78o1dsobqou3sc2aoojj3p